In the United States, pharmaceutical advertising is fraught with the potential for violating the stringent requirements outlined in the Food, Drug, and Cosmetic Act (FDCA) and Title 21 of the Code of Federal Regulations (CFR). The success of a pharmaceutical company, and its ability to disseminate critical information to relevant patients and healthcare providers, rests on ensuring their commercial teams achieve set marketing goals. To this end, these teams are only as successful as the support they receive, and they are reliant on the experience of the promotional review committee (PRC) to guide them.
This need will be magnified for pharmaceutical and medical device companies when launching a new product or even a new promotional campaign. It is an “all hands-on deck” event for the marketing team with high stakes, tight timelines, and the need for an experienced promotional review team to help guide, advise, and approve the proposed advertising, promotional, and educational materials. Having an experienced medical promotional reviewer on that team can be the difference in your material being simply compliant OR both compelling and compliant.
Don’t run your next advertising campaign before understanding the importance of having an experienced medical promotional reviewer supporting your team.